Samsung Biologics Co.,Ltd. Accounts Payable for the year ending December 31, 2024: USD 119.79 M

Samsung Biologics Co.,Ltd. Accounts Payable is USD 119.79 M for the year ending December 31, 2024, a -25.11% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Samsung Biologics Co.,Ltd. Accounts Payable for the year ending December 31, 2023 was USD 159.96 M, a 239.64% change year over year.
  • Samsung Biologics Co.,Ltd. Accounts Payable for the year ending December 31, 2022 was USD 47.10 M, a 74.47% change year over year.
  • Samsung Biologics Co.,Ltd. Accounts Payable for the year ending December 31, 2021 was USD 26.99 M, a -46.52% change year over year.
  • Samsung Biologics Co.,Ltd. Accounts Payable for the year ending December 31, 2020 was USD 50.48 M, a 376.46% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities